---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-145983"
form_type: "8-K"
ticker: "MREO"
cik: "0001719714"
company_name: "Mereo BioPharma Group plc"
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:15:39.931059+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# All seven proposals approved at Mereo BioPharma 2024 AGM; director re-elections pass with >91% support

## Summary
- Annual report adopted with 99.66% of votes cast in favor; PwC reappointed as auditor (99.60% support).
- Dr. Denise Scots-Knight re-elected as director (91.13% for), Dr. Jeremy Bender re-elected (92.46% for), Dr. Anders Ekblom re-elected (94.12% for).
- Directors' remuneration report approved with 98.63% of votes cast in favor.
- All votes based on 536,018,312 ordinary shares represented at the meeting.

## SEC filing metadata
- accession: 0001193125-24-145983
- form_type: 8-K
- ticker: MREO
- cik: 0001719714
- company_name: Mereo BioPharma Group plc
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719714/000119312524145983/0001193125-24-145983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719714/000119312524145983/d840193d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-145983
- JSON: https://secwatch.observer/filing/0001193125-24-145983.json
- Plain text: https://secwatch.observer/filing/0001193125-24-145983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.